Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci in prokaryotes are composed of 30-40-base-pair repeats separated by equally short sequences of plasmid and bacteriophage origin known as spacers [1] [2] [3] . These loci are transcribed and processed into short CRISPR RNAs (crRNAs) that are used as guides by CRISPR-associated (Cas) nucleases to recognize and destroy complementary sequences (known as protospacers) in foreign nucleic acids 4, 5 . In contrast to most Cas nucleases, which destroy invader DNA [4] [5] [6] [7] , the type VI effector nuclease Cas13 uses RNA guides to locate complementary transcripts and catalyse both sequence-specific cis-and non-specific trans-RNA cleavage 8 . Although it has been hypothesized that Cas13 naturally defends against RNA phages 8 , type VI spacer sequences have exclusively been found to match the genomes of double-stranded DNA phages 9, 10 , suggesting that Cas13 can provide immunity against these invaders. However, whether and how Cas13 uses its cis-and/or trans-RNA cleavage activities to defend against double-stranded DNA phages is not understood. Here we show that trans-cleavage of transcripts halts the growth of the host cell and is sufficient to abort the infectious cycle. This depletes the phage population and provides herd immunity to uninfected bacteria. Phages that harbour target mutations, which easily evade DNA-targeting CRISPR systems [11] [12] [13] , are also neutralized when Cas13 is activated by wild-type phages. Thus, by acting on the host rather than directly targeting the virus, type VI CRISPR systems not only provide robust defence against DNA phages but also prevent outbreaks of CRISPR-resistant phage.
, are also neutralized when Cas13 is activated by wild-type phages. Thus, by acting on the host rather than directly targeting the virus, type VI CRISPR systems not only provide robust defence against DNA phages but also prevent outbreaks of CRISPR-resistant phage.
We investigated the ability of Cas13a to provide phage resistance to Listeria, a natural host for the type VI-A CRISPR-Cas system, which we previously established as a model to study immunity against plasmid transfer 14 . We constructed Listeria ivanovii ΩCRISPR VI , a strain that is susceptible to infection by the phage φRR4 and carries the type VI-A CRISPR locus of Listeria seeligeri ATCC35967 (Extended Data Fig. 1a-c) . To study Cas13a-mediated phage immunity, we generated a spacer library containing 41,276 unique φRR4 sequences, tiled every two nucleotides across both strands of the phage genome (Supplementary Information 1). We introduced the spacer library into L. ivanovii ΩCRISPR VI and infected the cells with φRR4. We collected intact cells before and five hours after infection, and used next-generation sequencing to determine spacer abundance. Wild-type L. ivanovii RR3 cells decreased in optical density at 600 nm (OD 600 ) after infection, but the diverse set of spacers in the library provided protection from lysis (Extended Data Fig. 1d ). We calculated enrichment ratios for each spacer as the read count after infection divided by the number of initial reads. The observed enrichment ratios were modest, consistent with previously reported growth defects associated with Cas13a activation 8, 14 . As expected, given the fact that Cas13a targets RNA, we found a strong strand bias in spacer efficacy: spacers that generate a crRNA complementary to predicted transcripts (based on open reading frame direction) showed substantially higher enrichment ratios than those for which there should not be a target transcript (Fig. 1a . We selected three individual spacers from the library for further characterization: spcA, which targets the φRR4 anti-CRISPR region; spcE, which targets the early lytic genes; and spcL, which targets the late lytic genes (Extended Data Fig. 1a ). Each spacer strongly reduced both the efficiency of infective centre formation ( Fig. 1d ) and the phage burst size (Fig. 1e) . Together, these results show that Cas13a uses crRNAs complementary to phage transcripts to prevent the establishment and maintenance of infection.
The experiments described above demonstrated that, although different individual spacer sequences supported different levels of defence, spacers that matched either essential or non-essential transcripts (such as those produced by phage anti-CRISPR genes, see below), and earlyor late-expressed RNAs, could mediate a robust defence. This indicates 1 Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA. 2 Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA. *e-mail: ameeske@rockefeller.edu;
marraffini@rockefeller.edu Letter reSeArCH that the function of the target transcript cleaved by the cis-RNase activity of Cas13a does not affect the potency of the type VI-A immune response. To determine the extent of Cas13a-mediated trans-RNA degradation in vivo, we used conventional RNA-seq (Extended Data Fig. 3a ) as well as global mapping of RNA 5′ ends, a method that detects both the transcription start site (TSS) of primary transcripts and the products of Cas13a cleavage. We analysed both host-and phage-derived transcripts in the RR3, ΩCRISPR VI (spcE) and ΩCRISPR VI (spcL) strains of L. ivanovii after 105 min of infection with φRR4. In the absence of type VI-A immunity, we detected abundant peaks for each TSS over a background signal that is presumably derived from spurious RNA cleavage or alternative transcription initiation ( Fig. 2a-d) . By contrast, in ΩCRISPR VI (spcE) cells we detected extensive cleavage within the φRR4 early lytic transcript (Fig. 2a) as well as within host transcripts (Fig. 2c, Extended Data Fig. 3b) . Moreover, the average cleavage ratio (defined as the ratio of cleavage products to primary transcript reads) in ΩCRISPR VI (spcE) cells was significantly (P = 6.9 × 10 −64 ) higher than in RR3 control cells across all host transcripts (Fig. 2e, Supplementary  Information 2) . Transcripts of the late lytic operon were undetectable in ΩCRISPR VI (spcE) cells (Fig. 2a, Extended Data Fig. 3a) probably because the products of phage early lytic genes are required for late gene transcription. Similar results were obtained for ΩCRISPR VI (spcL) cells (Fig. 2b, d , f, Extended Data Fig. 3a, Supplementary Information 3) . We also detected cleavage of the early lytic transcripts in this strain, presumably as a consequence of trans-RNA degradation by Cas13a. Finally, similar degradation of host RNA was observed in the absence of phage infection, 15 min after activation of Cas13a by a chromosomally encoded target in L. seeligeri ATCC35967 (Fig. 3g , h, Extended Data Fig. 3c, Supplementary Information 4) . Together, these results indicate that trans-RNA cleavage by Cas13a leads to massive degradation of both host and invader RNA in vivo.
Whereas DNA-cleaving CRISPR-Cas systems provide immunity through direct destruction of the phage genome 7, 15 , we reasoned that the collateral RNA degradation deployed by type VI-A systems might lead to the depletion of host and phage factors that are required for phage DNA replication and thereby indirectly support the clearance of invader genomes. We used quantitative PCR (qPCR) to measure the abundance of phage DNA in the RR3 and ΩCRISPR VI strains over the course of φRR4 infection (Fig. 3a) . Phage DNA did not accumulate when early-expressed transcripts were targeted by spcA or spcE, probably because destruction of host and phage transcripts by Cas13a early in the lytic cycle prevented phage replication. By contrast, when Cas13a was programmed with spcL, phage DNA accumulated to similar levels to the RR3 control. This result indicates that Cas13a can interfere with phage infection at any time during the viral lytic cycle, through a mechanism that does not necessarily prevent the accumulation of phage DNA. We hypothesized that such a mechanism could be based on the growth defect observed during targeting of plasmids by Cas13 in both heterologous and native hosts 8, 14 . We looked for similar growth defects during phage infection by measuring the OD 600 of L. ivanovii RR3 and ΩCRISPR VI cultures after infection. Although we detected only mild growth defects at a multiplicity of infection (MOI) of 1 (Extended Data Fig. 4a) , at an MOI of 5, CRISPR targeting resulted in a marked growth delay of the cultures (Fig. 3b) . It has been hypothesized that, similarly to abortive infection systems that elicit phage defence in other bacteria [17] [18] [19] , massive host transcript degradation could result in dormancy of infected cells and thus prevent viral propagation 8, 16 . To test this idea, we assessed cell viability and phage titres before and immediately after infection at an MOI of 2, as well as after the first phage burst 4 h later (Fig. 3c, Extended Data Fig. 4b ). Only 10-20% of RR3 control cells lacking CRISPR remained viable immediately after infection, and these suffered a more pronounced loss after 4 h. By contrast, all three ΩCRISPR VI strains exhibited the same initial loss of viability but then recovered at 4 h, although they showed reduced numbers compared to uninfected control cultures (Fig. 3c, Extended Data Fig. 4c ). Phage titres mirrored these results, with substantial phage proliferation in RR3 cells during the first 4 h of infection, but a substantial decrease in phage propagation, even immediately after infection, in cells equipped with type VI-A immunity (Fig. 3d) .
These results support a model for Cas13a-mediated immunity in which infected cells stop proliferating and inactivate the phages that invaded them, thus providing passive protection to uninfected cells, which survive and proliferate. Indeed, a viability of 10-20% corresponds to the expected number of uninfected cells at an MOI of 2, which calculated using the Poisson distribution is 13%. To test this model, we first tested whether Cas13a activation elicits cell dormancy. We monitored growth (OD 600 ) after induction of a P tet -controlled target transcript by anhydrotetracycline (aTc) in the native type VI-A host, L. seeligeri ATCC35967 (Extended Data Fig. 5a ). Wild-type (but not ∆CRISPR) cells exhibited growth arrest, with no evidence of lysis. These cultures recovered upon removal of aTc and remained sensitive to re-exposure to the inducer (Extended Data Fig. 5b) , suggesting that the Cas13a-induced dormancy state is reversible. To test this more rigorously, we counted viable cells after induction of Cas13a targeting, plating culture samples on solid medium without aTc. Over the course of 9 h of target transcription and Cas13a activation, we observed a stable population of viable cells that could form colonies when aTc was removed (Fig. 3e) −64 , n = 1,027 transcripts, unpaired two-sided Student's t-test). f, As in e but for the experiment shown in d (P = 5.4 × 10 −32 , n = 1,092 transcripts). g, As in c but for wild-type and ∆CRISPR L. seeligeri strains after addition of aTc to induce target transcription. h, As in e but for the experiment shown in g (P = 6.9 × 10 −74 , n = 862 transcripts).
Letter reSeArCH activated cease to grow but do not die. Notably, these cells were not escape mutants that had lost CRISPR function; these accounted for only about 1% of the viable population after 9 h (Fig. 3e) Fig. 3c (Extended Data Fig. 5c ). By contrast, resorufin fluorescence remained constant over the course of the experiment in ΩCRISPR VI cultures (Extended Data Fig. 5d ), showing that most cells in the culture, including those not able to form a colony, stayed alive during infection. Together, these data show that, when activated by a target transcript, the RNase activity of Cas13a promotes a state of cell dormancy, rather than cell death. Although dormancy can be reversed by the inhibition of target transcription, it is maintained in infected cells where active phages continue to produce protospacer RNA.
Next, we investigated whether infected cells could provide herd immunity to uninfected cells in the population, as has been observed for other CRISPR types 12, 21, 22 . We found that phage-sensitive, chloramphenicol-resistant RR3 cells were protected from φRR4 infection when co-cultured with ΩCRISPR VI (spcE) cells (Fig. 3g) . Finally, we directly tested whether the cell dormancy triggered by activation of Cas13a is sufficient to protect against phage infection. We introduced a plasmid harbouring a target under an aTc-inducible promoter into L. ivanovii ΩCRISPR VI (spcP), which carries a spacer that matches the plasmid target, but not any of the phage transcripts. Pre-activation of Cas13a by aTc-induced target transcription resulted in a 6.7-fold reduction in φRR4 infection efficiency (Fig. 3h) . Furthermore, the plasmid-targeting strain showed a significant (P = 5 × 10 −4 ) survival advantage after 7 h of φRR4 infection (Extended Data Fig. 5e ). Together, these results demonstrate that the trans-RNA degradation activity of Cas13a is sufficient to provide immunity against double-stranded DNA (dsDNA) phages by inducing dormancy in infected cells, which prevents viral proliferation and protects uninfected cells in the population.
Our observation that plasmid-activated type VI-A CRISPR immunity also protected against infection by a phage not recognized by the crRNA guide of Cas13a demonstrates that these systems can provide general, non-specific immunity. This suggests that type VI-A systems could neutralize 'escaper' phages in the population, which contain target mutations that prevent their recognition by the crRNA guide. Such escaper phages easily overcome DNA-targeting CRISPR systems [11] [12] [13] but should not be able to successfully infect a host in which a previous infection by a wild-type phage activated Cas13a (a very likely scenario when escapers are rare in the phage population). Indeed, we were not able to detect escaper plaques on lawns of L. ivanovii ΩCRISPR VI (spcE) or ΩCRISPR VI (spcA) cells (Extended Data Fig. 6a, b) . To investigate the ability of type VI-A systems to protect against escaper phages, we engineered two φRR4 mutants that could escape spcA (φRR4 acr ) and spcE (φRR4
VI cells with these mutants and found that escaper phage propagation was reduced by 1-2 orders of magnitude when cells were co-infected (1:10 5 ratio) with wild-type φRR4 (Fig. 4a, c) . Moreover, we obtained similar results when we used the virulent myovirus A511 23 , a Listeria phage unrelated to φRR4, instead of the mutants (Fig. 4b, c ). Finally, we tested the prediction that the extent of escaper neutralization should increase with the MOI, as the probability of infection with a wild-type phage also increases. Indeed, cells pre-infected at higher MOIs with wild-type φRR4 showed reduced propagation of escaper phages (added at MOI 0.1 to pre-infected cells) (Fig. 4d) . Adsorption efficiency was unchanged after the first infection, excluding the possibility that competition for phage binding sites prevented the second Fig. 3 | Cas13a-induced cell dormancy is sufficient to abort lytic infection and limit phage propagation. a, Mean (± s.e.m., n = 3 biological replicates) phage DNA content after infection of L. ivanovii RR3 and ΩCRISPR VI (spcA, spcE or spcL) strains with φRR4 at an MOI of 1, normalized to value for RR3 cells 10 min after infection. b, Mean (± s.e.m., n = 3 biological replicates) OD 600 values of L. ivanovii RR3 and ΩCRISPR VI (spcA, spcE or spcL) cultures after infection with φRR4 at an MOI of 5. RR3-UN, uninfected RR3. c, Mean (± s.e.m., n = 6 biological replicates) CFU present in L. ivanovii RR3 and ΩCRISPR VI (spcA, spcE or spcL) cultures before (P), immediately after (0), and 4 h after infection with φRR4 at an MOI of 2. d, As in c but measuring PFU titre. e, Mean (± s.e.m., n = 3 biological replicates) CFU from L. seeligeri wild-type and ∆CRISPR cultures after transcription of a chromosomal target and plating on medium lacking aTc. Escaper mutants in the wild-type culture were counted on plates with aTc. f, Mean (± s.e.m., n = 3 biological replicates) survival of L. seeligeri wild-type and ∆CRISPR cultures in the presence of ampicillin (Amp), streptomycin (Str) or ciprofloxacin (Cip) after activation of Cas13. g, Mean (± s.e.m., n = 3 biological replicates) chloramphenicol-resistant CFU per ml before (P), 7 h after (7) and without (UN) infection with φRR4 at an MOI of 1 of a 1:1 mix of phage-susceptible, chloramphenicol-resistant (cm R ) L. ivanovii RR3 and chloramphenicol-sensitive L. ivanovii RR3 or ΩCRISPR VI (spcE) strains. h, Mean (± s.e.m., n = 3 biological replicates) ECOI after addition of φRR4 to phage-susceptible L. ivanovii ΩCRISPR VI (spcP) cells harbouring a plasmid with an aTc-inducible spcP target or an empty vector control. (and similarly, A511), co-infection with φRR4 acr did not prevent either φRR4 acr-esc or A511 from escaping Cas9 targeting. Therefore, crossprotection is a feature of Cas13a targeting, and not a φRR4-specific phenomenon, such as superinfection exclusion. Together, these data indicate that type VI-A immunity against wild-type φRR4 crossprotects against infection by both protospacer escape mutant phages and other unrelated viruses. Thus, by acting on the infected host rather than directly on the target phage, Cas13a activation leads to broad and nonspecific immunity against dsDNA phages.
We have shown that during the type VI-A CRISPR-Cas response against dsDNA phages, the RNase Cas13a performs crRNA-guided recognition of phage RNA, resulting in massive degradation of host and phage transcripts. Although it is possible that this degradation interferes with the phage lytic cycle to contribute to overall defence, we believe that the fundamental feature of type VI-A immunity is the dormancy of the host cell produced by the destruction of host transcripts. This is similar to other phage defence strategies known as abortive infection 24 . We postulate that, in the absence of a mechanism to specifically destroy the phage DNA, target transcription continues, Cas13a remains active and the host cells neither resume growth nor lyse. Therefore, the infected cell can continue to adsorb phages, abort their infectious cycle and eliminate them from the culture.
To our knowledge, all other CRISPR types studied possess DNA cleavage activities that can destroy the genome of an infecting phage 6, 7, 15, 25, 26 . Therefore immunity is achieved by a direct attack on the invader, followed by survival of the infected cells. A consequence of direct interference with the phage lytic cycle is that mutant escapers can overcome targeting, kill the infected cell and propagate. By contrast, during type VI-A CRISPR-Cas immunity, the small fraction of escaper phages present in the viral population are likely to end up infecting a cell in which Cas13a was previously activated by a wild-type, target-bearing phage, and are therefore also neutralized. Phage density, escaper frequency, and spacer targeting efficiency are all likely to affect the extent of this cross-protection mechanism.
Instead of using abortive infection to limit the propagation of escaper phages, the DNA-degrading CRISPR systems usually acquire new spacer sequences that can target other regions of the phage 12 . Given the negative selection suffered by cells in which type VI-A immunity is triggered, and the strong protection against escapers provided by Cas13a, it is unclear how spacer acquisition might operate in these systems. One possibility is that spacers are acquired from the injected genomes of defective phage particles that fail to activate their transcriptional program 27 . Alternatively, phage genomes could occasionally be cleared from the cell after Cas13a activation, permitting the cell to recover from dormancy. If such a mechanism exists, the infected cell itself would benefit from the presence of the type VI CRISPR system and immunity would not be an exclusively altruistic event.
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Methods
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Bacterial strains and growth conditions. The type VI CRISPR system was derived from L. seeligeri ATCC strain 35967 (Rocourt and Grimont). L. seeligeri RR4 and L. ivanovii RR3 were obtained from J.-P. Lemaître (INRA, Dijon, France). All Listeria strains were propagated in Brain Heart Infusion (BHI) broth or agar at 30 °C. Unless otherwise stated, plasmids were cloned in Escherichia coli DH5α, miniprepped, and transformed into the conjugative donor strain E. coli SM10 for conjugative mating. All E. coli strains were cultured in lysogeny broth (LB) at 37 °C. Phage isolation and propagation. Isolation of φRR4 was carried out by overnight induction of L. seeligeri RR4 at OD 0.1 using mitomycin C at 2 µg/ml. The induced culture supernatant was diluted to single plaques on a lawn of L. ivanovii, and a single plaque was purified twice to ensure homogeneity. To generate high-titre phage lysates, 50 ml of L. ivanovii culture was infected with φRR4 at MOI 0.1, OD 0.1 and the infection proceeded overnight. The lysate was filtered and concentrated to 1 ml using Amicon Ultra 100MWCO columns. Infective centre and burst size quantification. L. ivanovii strains were grown to mid-exponential phase, and 0.6 ml of culture at OD 600 0.5 was infected with φRR4 or derivatives at an MOI of 0.1. Adsorption was carried out for 5 min, followed by three washes with 1 ml BHI to remove unbound phage, and the samples were resuspended to a final volume of 1 ml. Infective centres were enumerated by measuring PFU titres on a lawn of naive L. ivanovii RR3 at the initial time point. Burst size was calculated by dividing the PFU after the first burst by the starting PFU. E. coli-Listeria conjugation. Donor E. coli SM10 or β2163 ∆dapA strains carrying E. coli-Listeria shuttle vectors were cultured in LB containing 100 µg/ml ampicillin (for pAM8-derived vectors) or 25 µg/ml chloramphenicol (for pPL2e-derived vectors). Recipient L. seeligeri or L. ivanovii strains were cultured in BHI. Saturated donor and recipient cultures (100 µl each) were combined in 10 ml BHI, and concentrated onto a 0.45-µm membrane filter, which was then overlaid onto a BHI agar plate containing 8 µg/ml oxacillin, which weakens the cell wall, enhancing conjugation. Mating plates were incubated for 4 h at 37 °C, then cells were resuspended in 2 ml BHI and plated at 30 °C on selective BHI medium containing 50 µg/ml nalidixic acid (which kills donor E. coli but not recipient Listeria). Selection for plasmid recipients was performed with either 15 µg/ml chloramphenicol (for pAM8-derived vectors) or 1 µg/ml erythromycin (for pPL2e-derived vectors). Cloning of CRISPR locus and spacer library construction. The L. seeligeri type VI CRISPR locus was introduced into L. ivanovii RR3 by cloning into the PSA site-specific integrating vector pPL2e 28 via three-piece Gibson assembly using (1) a synthetic gene fragment containing the native promoter and CRISPR array modified to contain only two repeats and BsaI sites for spacer cloning (amplified with oAM462/127), (2) the cas13a gene (amplified with oAM463/94), and (3) BamHI-SalI-digested pPL2e, resulting in the plasmid pAM125. Cloning of individual spacers was carried out by ligation of annealed oligos into BsaI-digested pAM125. For spacer library construction, a library of 41,276 × 85-nt oligonucleotides, each containing a unique φRR4-matching spacer, repeat homology, BsaI sites, and universal priming sites, was purchased from Twist Biosciences. The library was made double-stranded by PCR and the product was purified by phenolchloroform extraction. Spacers were introduced into pAM125 via Golden Gate cloning with BsaI-HFv2 (New England Biolabs) and T7 DNA ligase, then electroporated into Endura Duo electrocompetent cells. Four hundred thousand colonies were pooled, and the plasmids were isolated and electroporated into the conjugative donor strain β2163 ∆dapA in the presence of 1.2 mM diaminopimelic acid (DAP). Conjugation into L. ivanovii was carried out as described above, except for the presence of 1.2 mM DAP during mating. Transconjugants were isolated in the presence of erythromycin (to select for ΩCRISPR VI integration) and the absence of DAP to prevent growth of the auxotrophic donor E. coli. The ΩCRISPR II strain was constructed by cloning the type II-A CRISPR-Cas9 system from S. pyogenes into the E. coli-Listeria shuttle vector pAM8 14 . A single spacer was retained with two SapI sites for spacer cloning (pAM307). Cloning of individual spacers was carried out by ligation of annealed oligos into SapI-digested pAM307. A pAM307 variant carrying φRR4 spcE (pAM325) was conjugated into L. ivanovii, selecting on medium containing 50 µg/ml nalidixic acid and 15 µg/ml chloramphenicol to generate ΩCRISPR II .
Gene deletions and replacements in Listeria.
Allelic replacement in L. seeligeri or L. ivanovii was conducted as previously described 14 . In brief, 1-kb homologous sequences flanking each side of the region to be replaced were cloned into pAM215, a suicide plasmid unable to replicate in Listeria, that also carries lacZ and chloramphenicol resistance (cat) markers. This plasmid was transferred to Listeria strains via conjugation as described above, and 100 µl of resuspended cells was plated for selection on 50 µg/ml nalidixic acid and 15 µg/ml chloramphenicol. Isolated transconjugants (integrants) were streak-purified and confirmed lacZ+ by patching on BHI plates containing 100 µg/ml 5-bromo-4-chloro-3-indolyl β-d-galactopyranoside (X-gal). Integrants were passaged (grown to saturation, then diluted 1,000-fold) 3-4 times in BHI without selection. Passaged cultures were diluted and plated on BHI X-gal, and incubated for 2-3 days at 37 °C. White (lacZ -) colonies (excisants) were isolated, confirmed chloramphenicol-sensitive, and checked for the deletion by PCR using primers flanking the desired deletion followed by Sanger sequencing. Bacterial genome sequencing and assembly. Chromosomal DNA was prepared from 2-ml cultures of L. seeligeri RR4 and L. ivanovii RR3 via lysozyme treatment and phenol-chloroform extraction and ethanol precipitation. DNA samples were sheared using a Covaris sonicator and prepared for deep sequencing using the Illumina TruSeq Nano DNA LT kit, and paired-end 2 × 300-bp sequencing was conducted on the MiSeq platform. Reads were quality-trimmed using Sickle (https://github.com/najoshi/sickle), and assembled into contigs using Abyss (https://github.com/bcgsc/abyss). Finally, contigs were mapped to reference L. seeligeri and L. ivanovii genomes using Medusa (http://combo.dbe.unifi.it/medusa). Automated genome annotation was performed using BaSys (https://www.basys. ca). Raw reads and assembled genomes have been deposited to GenBank under BioProject accession number PRJNA512236. Spacer selection, deep sequencing and analysis. The spacer library was grown to OD 0.3 and a pre-infection sample was harvested. The remaining culture was infected with φRR4 at an MOI of 1, and surviving cells were harvested 5 h later. Chromosomal DNA was prepared from both samples, and the CRISPR array was amplified using oAM459/16. Library preparation from the resulting PCR products was conducted using the Illumina TruSeq Nano DNA LT kit, followed by 150-bp single-end sequencing using the MiSeq platform. Spacer sequences flanked by perfect repeats were extracted and mapped to the φRR4 genome using bowtie2. Reads at each position in the genome were calculated and normalized to total spacer reads, and the enrichment ratio for a given spacer was calculated as the post-infection read count divided by the pre-infection read count. Spacers with fewer than 10 reads before infection were discarded to reduce noise (26,766 spacers retained). Raw sequencing reads for each time point have been deposited under BioProject accession number PRJNA512236. RNA sequencing. To isolate RNA from Listeria, the equivalent of 3 ml culture at OD 600 0.5 was pelleted and lysed by 3 min treatment with 2 mg/ml lysozyme followed by the addition of sarkosyl at 1%. A fixed amount of Staphylococcus aureus RNA was added to each sample immediately after lysis for global RNA normalization. RNA was purified from these lysates using the Zymo Direct-Zol RNA miniprep plus kit according to the manufacturer's instructions. Genomic DNA was eliminated using the Ambion Turbo DNase-free kit. Ribosomal RNA was depleted using the Illumina Ribo-Zero rRNA removal (Bacteria) kit. After rRNA removal, libraries were prepared for deep sequencing using the TruSeq Stranded mRNA Library prep kit, skipping mRNA purification and beginning at the RNA fragmentation step. Paired-end (2 × 75-bp) sequencing was performed on the NextSeq platform. Paired-end sequencing data for phage-infected L. ivanovii RR3, ΩCRISPR VI (spcE), and ΩCRISPR VI (spcL) strains, as well as aTc-treated L. seeligeri wild-type (Ptet-spc4) and ∆CRISPR (Ptet-spc4) strains, have been deposited under BioProject accession number PRJNA512236.
For 5′ end mapping, RNA was first purified, DNase-treated and rRNA depleted as above, then concentrated using the Zymo RNA Clean & Concentrator 5 kit and 5′ phosphorylated with T4 polynucleotide kinase (NEB). 5′ triphosphates were removed using E. coli polyphosphatase, and a 5′ RNA adaptor was added using T4 RNA ligase. The library was fragmented using Agilent RNA fragmentation reagents, and reverse transcribed using SuperScript IV with an adaptor primer ending in nine randomized nucleotides. The resulting cDNA libraries were amplified by PCR and purified using AMPure beads, then single-end 150-bp sequencing was carried out on the MiSeq platform. 5′ end sequencing data for phage-infected L. ivanovii RR3, ΩCRISPR VI (spcE), and ΩCRISPR VI (spcL) strains, as well as aTc-treated L. seeligeri wild-type (Ptet-spc4) and ∆CRISPR (Ptet-spc4) strains, have been deposited under BioProject accession number PRJNA512236. RNA-seq analysis. RNA-seq reads were mapped to the corresponding genome using bowtie2. Coverage was calculated at each genome position and normalized to the total number of S. aureus reads (representing the spike-in), and the ratio of CRISPR + :CRISPR -reads was calculated. If zero reads were detected, a pseudocount was added. For RNA 5′ end mapping analysis, reads were mapped as above, with only the 5′ end position tabulated. Operonic transcripts were manually annotated from the paired-end transcriptomic data, and these boundaries were used to calculate the fraction of reads that mapped within or outside the TSS. The site within 500 nucleotides upstream of the start codon containing the most 5′ reads in wild-type cells was designated as the TSS. Reads mapping within five nucleotides of this site were counted as TSS reads. For transcripts in which at least 20 reads were detected in each sample, the cleavage ratio was calculated as the read count downstream of the TSS divided by that within the TSS. Normalization to the TSS accounts for differences in gene expression generated by pleiotropic effects such as the degradation of transcription factor mRNAs. This cleavage ratio also allowed us to capture events in which Cas13a-mediated degradation did not produce stable cleavage products. Tables are provided showing Information 3) , and aTc-treated L. seeligeri wild-type (Ptet-spc4) and ∆CRISPR (Ptet-spc4) (Supplementary Information 4) strains. φRR4 escaper mutant construction. φRR4 mutants were generated by allelic exchange using the integration of the suicide vector pAM215 into the L. seeligeri RR4 lysogen as described above. Mutant prophages were confirmed by PCR and sequencing, and induced with mitomycin C as described above. Herd immunity experiment. L. ivanovii RR3 cells carrying a cat gene encoding resistance to chloramphenicol were co-cultured at a 1:1 ratio with either wild-type RR3 or ΩCRISPR VI (spcE) cells, then the population was infected with φRR4 at OD 600 = 0.1, MOI 1, for 7 h at 30 °C. Viable chloramphenicol-resistant cells were counted before and 7 h after infection. Immunity by plasmid targeting. L. ivanovii ΩCRISPR VI (spcP) cells were transformed with pAM211 (empty vector) or pAM212 (aTc-inducible spcP target) via conjugative mating. Cells carrying each plasmid and the CRISPR locus were grown to OD 600 = 0.1, and exposed to 100 ng/ml aTc for 1h. Then, cells were infected with φRR4 at MOI 1 for 7 h at 30 °C. Viable CFUs were counted before and after infection. Alternatively, the efficiency of φRR4 infective centre formation was measured on cells 1 h after aTc treatment. Cell vitality assay. Cell vitality was measured with the resazurin-based cell vitality reagent alamarBlue HS (ThermoFisher) according to the manufacturer's instructions. In brief, 100 µl of cell culture was mixed with 10 µl of alamarBlue HS and incubated for 20 min while shaking at 37 °C, and fluorescence (excitation: 560 nm, emission: 590 nm) was measured on a Tecan Infinite M200 Pro plate reader with monochromator module with a fixed gain setting of 79. Uninfected cells in the same medium as all experimental samples were used as live cell standards, and the same samples heated for 5 min at 95 °C were used as dead cell standards. We made 10% and 50% live cell mixture standards to assess the accuracy of vitality measurements. Dead cell signal was subtracted as background from all resorufin signal values. Resorufin signal values for all samples were normalized to values before infection. Phage co-infection plaque assays. For phage co-infection assays to assess the efficiency of escaper infection in the presence and absence of co-infecting wild-type phage, escaper phage stocks were diluted to approximately 5 × 10 4 PFU/ml in BHI medium, then mixed with BHI containing either no phage or 5 × 10 9 PFU/ml wild-type φRR4. Serial tenfold dilutions of phage mixtures were made and 2 µl of each dilution was spotted onto BHI top agar lawns seeded with 100 µl of saturated cultures of ΩCRISPR VI strains. φRR4 acr escaper mixtures were spotted onto ΩCRISPR VI (spcA) lawns, and φRR4 early escaper mixtures were spotted on ΩCRISPR VI (spcE) lawns. A511 mixtures were spotted onto both targeting lawns. Co-infections comparing Cas9 and Cas13 were conducted in the same way, except that φRR4 acr was used as the activating phage, and was mixed in 10 5 -fold excess with φRR4 acr-esc or A511. Mixtures were spotted onto BHI top agar lawns seeded with 100 µl of saturated ΩCRISPR VI (spcE) or ΩCRISPR II (spcE) culture. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
The L. seeligeri RR4 and L. ivanovii RR3 genome sequences, along with raw reads from the spacer library deep sequencing, paired-end RNA-seq, and 5′ end mapping have been deposited in the Sequence Read Archive under BioProject accession number PRJNA512236. Lists of strains, plasmids, and oligonucleotides used in this study are available in Supplementary Information 5.
Code availability
Custom scripts used in analysis of spacer library data as well as RNA 5′ end mapping data are available upon request. Arrowhead indicates addition of 100 ng ml -1 aTc. Each data point represents the mean ± s.e.m. of three biological replicates. b, Wildtype and ∆CRISPR L. seeligeri cultures carrying an aTc-inducible target transcript were exposed to 100 ng ml -1 aTc for 3 h as in a, then diluted (at time 0 h) to OD 600 = 0.05 in fresh medium in the presence or absence of aTc, and growth was monitored over 24 h. Each curve represents the mean ± s.e.m. of three biological replicates. c, Immediate reduction in CFU upon phage infection of L. ivanovii RR3 or ΩCRISPR VI strains. The indicated strains were infected with φRR4 at an MOI of 2, and CFU titres in the infected cultures were monitored over time. Pre-infection (P) and mock-infection titres were also measured. Each bar represents the mean ± s.e.m. of three biological replicates. d, Cell vitality within ΩCRISPR VI cultures during phage infection. Cell vitality was measured in samples of cultures from c by monitoring conversion of nonfluorescent resazurin to fluorescent resorufin at each time point. The resorufin signal from heat-killed cells was subtracted from all samples as background, and each signal was normalized to the pre-infection value. Live cell standards (10% and 50%, mixed with heat-killed cells) are shown to demonstrate the quantitative capability of the vitality assay. Each bar represents the mean ± s.e.m. of three biological replicates. e, Phage-susceptible L. ivanovii ΩCRISPR VI (spcP) cells harbouring a spacer against an aTc-inducible plasmid target RNA (or empty vector control) were treated with aTc for 1 h to pre-activate Cas13a, then infected with φRR4 at an MOI of 1. Viable CFUs were counted before infection (PRE), 7 h after infection (T7) or after mock infection (UN). Two-sided Student's t-test, ***P = 0.0005. Each bar represents the mean ± s.e.m. of three biological replicates.
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Extended Data Fig. 6 acr mutant, harbouring a deletion of the putative anti-CRISPR genes of φRR4. d, Design of the φRR4 early mutant, depicting the wild-type and mutant spcE target sequence. e, Cells pre-infected with wild-type φRR4 continue to adsorb escaper phage 2 h after infection. ΩCRISPR VI (spcE) cells were infected with wild-type φRR4 at an MOI of 5 for 2 h (an uninfected control is shown for comparison), then washed three times with fresh medium to remove free phages. φRR4 early was added to cells (or to a cell-free control) at an MOI of 0.1 for 5 min, cells and bound phage were pelleted, and free phage in the supernatant were quantified as PFUs on a lawn of ΩCRISPR VI (spcE) cells. Mean PFU values are shown from two biological replicates. f, Efficiency of plaqueforming assay using RR3 and ΩCRISPR II (spcE) strains. We generated a ΩCRISPR II (spcE) strain carrying the type II-A CRISPR system from S. pyogenes programmed with spcE against φRR4. This strain has very limited immunity to wild-type φRR4, but is highly immune to the φRR4 acr mutant, which lacks anti-CRISPR-Cas9 genes. Cas9-resistant φRR4 acr escaper plaques are evident in the plaque assay (yellow arrowheads). One escaper, φRR4 acr-esc , was isolated and confirmed to be resistant to Cas9 targeting. Representative of two biological replicates Corresponding author(s): Luciano Marraffini Last updated by author(s): Apr 15, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
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Code Availability statement: Custom scripts used in analysis of spacer library data as well as RNA 5' end mapping data are available upon request.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The L. seeligeri RR4 and L. ivanovii RR3 genome sequences, along with raw reads from the spacer library deep sequencing, paired end RNA-seq, and 5' end mapping have been deposited in the Sequence Read Archive under BioProject accession number PRJNA512236. Lists of strains, plasmids, and oligonucleotides used in this study are available in Supplementary Information 5.
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Sample size
No sample size calculation was performed. All experiments were performed with sample sizes based on standard protocols in the field.
Data exclusions In spacer library analysis, spacers with fewer than 10 reads (pre-infection) were discarded to reduce noise and report accurate enrichment values.
For transcript 5' end analysis, the transcriptional start sites could not be accurately determined for transcripts with fewer than 20 reads, therefore these data were excluded from analysis.
